<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29641" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Biochemistry, Substance P</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Graefe</surname>
            <given-names>Steven B.</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rahimi</surname>
            <given-names>Nader</given-names>
          </name>
          <aff>Boston University Medical Campus, Boston, MA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mohiuddin</surname>
            <given-names>Shamim S.</given-names>
          </name>
          <aff>Imam Abdulrahman Bin Faisal University, Dammam</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Steven Graefe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nader Rahimi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shamim Mohiuddin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>30</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29641.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Substance P (SP) is an 11-amino acid-long neuropeptide expressed by the central nervous system (CNS), the peripheral nervous system, and immune cells. SP is a member of the tachykinin (TAC) family of neuropeptides encoded by the TAC1 gene. SP elicits its activity via interacting with the G protein-coupled neurokinin receptors (NKRs), including NK1R, NK2R, and NK3R. NKRs are expressed on the surface of various cell types, including the blood vessels and lymphatics endothelial cells, immune cells, fibroblasts, and neurons.</p>
        <p>Activation of NKRs stimulates inositol trisphosphate/diacylglycerol (IP3/DAG) and cyclic adenosine monophosphate (cAMP) second messenger in a cell context-dependent manner. Activation of NKRs mediates complex neuronal signaling pathways linked to sensations and emotional responses. Emerging evidence suggests that&#x000a0;substance P plays other vital roles in inflammation, wound healing, and angiogenesis. Agents that inhibit substance P activity are currently being investigated as potential drugs for pain relief and other clinical conditions.</p>
      </sec>
      <sec id="article-29641.s2" sec-type="Fundamentals">
        <title>Fundamentals</title>
        <p>The biological activity of substance P is mediated through NK receptors. The NK receptors belong to the G protein&#x02013;coupled receptors (GPCRs). Activation of NK receptors stimulates inositol trisphosphate/diacylglycerol (IP3/DAG) and cyclic adenosine monophosphate (cAMP), leading to complex signaling events in a context-dependent manner.&#x000a0;</p>
        <p>NK receptor activation involves phosphorylation of the C-terminal of the domain of the NK receptor by G protein&#x02013;coupled receptor kinases, which results&#x000a0;in the recruitment of with b-arrestin adapter to the NK receptor. &#x003b2;-Arrestin plays a key role in the desensitization of cells to SP signaling.&#x000a0;</p>
      </sec>
      <sec id="article-29641.s3" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Current strategies to target SP in human diseases such as gastrointestinal, respiratory inflammation, and other conditions are heavily concentrated upon blocking its high-affinity receptor NK1R via small peptide or non-peptide NK1R antagonists. However, none of the SP against have reached clinical use.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-29641.s4" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>In mammals, there are three tachykinins (TAC) neuropeptides; substance P, neurokinin A (NKA), and neurokinin B (NKB). All TACs are derived from alternate spicing of TAC genes that are widely expressed throughout the nervous and immune systems. The biological function of SP is mediated through the binding of SP with the tachykinin receptors (NK1R, NK2R, NK3R).<xref ref-type="bibr" rid="article-29641.r1">[1]</xref> NK receptors are a member of the seven-transmembrane, G protein-coupled receptors (GPCRs).</p>
        <p>Substance P displays a greater affinity toward NK1R than NK2R and NK3R. Similar to GPCRs, NK receptors are composed of seven hydrophobic transmembrane domains, three extracellular (EL1, EL2, and EL3) domains, and three intracellular loops (C1, C2, and C3). The N-terminus tail of NK receptors faces the extracellular space, and the C-terminal faces the intracellular space. SP binds to loop C3, located in the second and third transmembrane domains of the NK receptors.<xref ref-type="bibr" rid="article-29641.r2">[2]</xref><xref ref-type="bibr" rid="article-29641.r1">[1]</xref><xref ref-type="bibr" rid="article-29641.r3">[3]</xref></p>
        <p>SP-induced activation of NK receptors often produces different cellular responses. For example, in astrocytes, SP binding leads to the activation of phospholipase C, which stimulates IP3 and DAG levels,&#x000a0;whereas, in smooth muscle cells, it stimulates cAMP.<xref ref-type="bibr" rid="article-29641.r4">[4]</xref><xref ref-type="bibr" rid="article-29641.r5">[5]</xref> These processes ultimately control the release of cytokines and regulate ion channel activity. Yet, activation of the same pathway in immune cells regulates the release of inflammatory cytokines.<xref ref-type="bibr" rid="article-29641.r6">[6]</xref><xref ref-type="bibr" rid="article-29641.r7">[7]</xref><xref ref-type="bibr" rid="article-29641.r8">[8]</xref><xref ref-type="bibr" rid="article-29641.r9">[9]</xref><xref ref-type="bibr" rid="article-29641.r10">[10]</xref><xref ref-type="bibr" rid="article-29641.r11">[11]</xref><xref ref-type="bibr" rid="article-29641.r12">[12]</xref>&#x000a0;</p>
        <p>Upon binding of SP to NKRs, the receptor rapidly undergoes internalization and subsequent degradation or recycling, which is mediated through the interaction of beta-arrestin with NKRs.<xref ref-type="bibr" rid="article-29641.r13">[13]</xref> This recycling appears to be controlled by inflammatory and anti-inflammatory cytokines and, in certain conditions, by SP.<xref ref-type="bibr" rid="article-29641.r14">[14]</xref><xref ref-type="bibr" rid="article-29641.r15">[15]</xref><xref ref-type="bibr" rid="article-29641.r16">[16]</xref><xref ref-type="bibr" rid="article-29641.r17">[17]</xref><xref ref-type="bibr" rid="article-29641.r18">[18]</xref>&#x000a0;</p>
        <p>Unbound&#x000a0;SP becomes hydrolyzed by peptidases, specifically by p-endopeptidase in the extracellular fluid and angiotensin-converting hormone (ACE) in the blood plasma.<xref ref-type="bibr" rid="article-29641.r19">[19]</xref>&#x000a0;SP&#x000a0;has a longer half-life in the plasma than in the tissues, lasting from seconds to minutes in the extracellular fluid of tissue cells to hours in the plasma.<xref ref-type="bibr" rid="article-29641.r20">[20]</xref><xref ref-type="bibr" rid="article-29641.r21">[21]</xref></p>
      </sec>
      <sec id="article-29641.s5" sec-type="Molecular Level&#x0000d;&#x0000a;">
        <title>Molecular Level
</title>
        <p>Substance P belongs to a large family of structurally related neuropeptides and was the first member of the tachykinin family of peptides to be discovered; it is often referred to as a pioneering neuropeptide. They are also called tachykinins because of their ability to rapidly stimulate the contraction of intestinal muscle in contrast to the slower-acting bradykinins. Tachykinins are produced from the alternative processing of TAC genes and interact with three NK receptors. They possess a conserved carboxy-terminal sequence (-Phe-X-Gly-Leu-Met-NH2, X hydrophobic), which is required for their ability to interact and activate NK receptors.</p>
        <p>The major human tachykinins are SP, neurokinin A (NKA), and neurokinin B (NKB), along with the NH2-terminally extended forms of NKA, such as neuropeptide K (NPK) and neuropeptide gamma. TAC1 gene encodes SP, NKA, NPK, and NP-gamma; TAC3 encodes NKB; and TAC4 encodes HK-1 and EKA, EKB, EKC, and EKD.<xref ref-type="bibr" rid="article-29641.r22">[22]</xref><xref ref-type="bibr" rid="article-29641.r23">[23]</xref><xref ref-type="bibr" rid="article-29641.r24">[24]</xref><xref ref-type="bibr" rid="article-29641.r25">[25]</xref><xref ref-type="bibr" rid="article-29641.r26">[26]</xref><xref ref-type="bibr" rid="article-29641.r27">[27]</xref></p>
        <p>SP&#x000a0;is an amphiphilic molecule that appears to interact with the phospholipid bilayer of plasma membranes. However, research has found no cellular process is associated with its amphiphilic nature.<xref ref-type="bibr" rid="article-29641.r28">[28]</xref> SP works primarily through interaction with its receptors.<xref ref-type="bibr" rid="article-29641.r4">[4]</xref><xref ref-type="bibr" rid="article-29641.r8">[8]</xref><xref ref-type="bibr" rid="article-29641.r29">[29]</xref><xref ref-type="bibr" rid="article-29641.r30">[30]</xref><xref ref-type="bibr" rid="article-29641.r31">[31]</xref><xref ref-type="bibr" rid="article-29641.r32">[32]</xref></p>
      </sec>
      <sec id="article-29641.s6" sec-type="Function">
        <title>Function</title>
        <p>Substance P is expressed throughout the nervous and immune systems; it regulates diverse physiological processes and has been implicated in various pathological conditions.&#x000a0;</p>
        <p>
<bold>Pain</bold>
</p>
        <p>The most studied role of SP is its role in pain perception. Free nerve endings (C-fibers) in the skin contain nociceptors and thermoreceptors that sense pain and temperature, respectively. The pain signal from the free nerve ending travels along small, unmyelinated axons to synapse in the spinal cord. In the presynaptic axon terminal are vesicles containing&#x000a0;SP and glutamate, which are released into the synaptic cleft of the dorsal horn. The hypothesis is that&#x000a0;SP helps sensitize the postsynaptic neurons to glutamate, aiding in transmitting pain signals to the somatosensory area of the brain.<xref ref-type="bibr" rid="article-29641.r33">[33]</xref><xref ref-type="bibr" rid="article-29641.r34">[34]</xref><xref ref-type="bibr" rid="article-29641.r35">[35]</xref><xref ref-type="bibr" rid="article-29641.r36">[36]</xref></p>
        <p>
<bold>Neurogenic Inflammation</bold>
</p>
        <p>While pain signals travel along axons of the somatosensory area of the brain, sensory neurons also release neurosecretory products in the area of the damaged tissue.<xref ref-type="bibr" rid="article-29641.r37">[37]</xref> These neurosecretory products include SP and calcitonin-gene-related peptide (CGRP). The release of these chemicals leads to the degranulation of mast cells, vasodilation through relaxation of vascular smooth muscle, and chemotaxis of immune system cells. These events collectively lead to a process called the wheel &#x00026; flare response.<xref ref-type="bibr" rid="article-29641.r38">[38]</xref></p>
        <p>This process is one of the ways the nervous system can direct the immune system to the site of damage/infection. This interaction between the immune system and the nervous system is termed neurogenic inflammation. Neurogenic inflammation is involved in the pathogenesis of many disease processes, including eczema, dermatitis, psoriasis, migraines, asthma, fibromyalgia, and rosacea.<xref ref-type="bibr" rid="article-29641.r39">[39]</xref></p>
        <p>
<bold>Immune Cells/Proliferation/Chemotaxis</bold>
</p>
        <p>SP also appears to contribute to the attraction of immune cells to the site of inflammation.<xref ref-type="bibr" rid="article-29641.r40">[40]</xref><xref ref-type="bibr" rid="article-29641.r7">[7]</xref><xref ref-type="bibr" rid="article-29641.r9">[9]</xref> Research with NK1-R knockout mice showed impaired migration of neutrophils to the site of inflammation, showing the&#x000a0;SP is involved in the response of neutrophils to IL-1bet&#x000a0;and the movement of immune cells through indirect mechanisms that induce cytokines that lead to the recruitment of macrophages and dendritic cells and helps stimulate the expression of interleukin-8 (IL-8), which is involved in neutrophil recruitment.<xref ref-type="bibr" rid="article-29641.r12">[12]</xref><xref ref-type="bibr" rid="article-29641.r41">[41]</xref><xref ref-type="bibr" rid="article-29641.r42">[42]</xref><xref ref-type="bibr" rid="article-29641.r43">[43]</xref><xref ref-type="bibr" rid="article-29641.r44">[44]</xref><xref ref-type="bibr" rid="article-29641.r45">[45]</xref>&#x000a0;Additionally, research has shown&#x000a0;SP to increase the expression of endothelial-leukocyte adhesion molecules (ELAM-1) on microvascular endothelial cells leading to the movement (diapedesis) of leukocytes.<xref ref-type="bibr" rid="article-29641.r46">[46]</xref><xref ref-type="bibr" rid="article-29641.r47">[47]</xref><xref ref-type="bibr" rid="article-29641.r48">[48]</xref><xref ref-type="bibr" rid="article-29641.r49">[49]</xref></p>
        <p>
<bold>Cardiovascular</bold>
</p>
        <p>SP, along with its NK1R, is involved in regulating heart rate, blood pressure, ischemia, reperfusion, cardiac response to stress, and angiogenesis.&#x000a0;SP is best known as a potent vasodilator.<xref ref-type="bibr" rid="article-29641.r5">[5]</xref> The vasodilatory effects of&#x000a0;SP are dependent on the nitric oxide production of endothelium cells, which leads to smooth muscle relaxation and, ultimately, the dilation of the blood vessel. As a result, intravenous administration of&#x000a0;SP results in decreased blood pressure.<xref ref-type="bibr" rid="article-29641.r50">[50]</xref></p>
        <p>SP&#x000a0;and NK1 receptors are found in cardiac muscle and may factor into the pathogenesis of myocardial infarction, myocarditis, and reperfusion injury. Interestingly, in a study using a capsaicin-treated heart (a substance that depletes SP and calcitonin gene-related peptide), acute infarction resulted in more irreversible injury to myocardial tissue than a non-capsaicin-treated heart. Therefore, the hypothesis is that SP and calcitonin gene-related peptide are involved in the reduction of reperfusion injury through the acute vasodilation of coronary arteries.<xref ref-type="bibr" rid="article-29641.r51">[51]</xref><xref ref-type="bibr" rid="article-29641.r52">[52]</xref><xref ref-type="bibr" rid="article-29641.r53">[53]</xref> However, in the long term,&#x000a0;SP also plays a role in cardiac remodeling and fibrosis by activating cardiac mast cells and upregulating endothelium-1 in cardiomyocytes.<xref ref-type="bibr" rid="article-29641.r54">[54]</xref></p>
        <p>
<bold>Respiratory</bold>
</p>
        <p>SP&#x000a0;is implicated in the pathogenesis of asthma and chronic bronchitis.&#x000a0;SP induces constriction of bronchial smooth muscle cells, which reduces the airway diameter and triggers mast cell degranulation in lung tissue.<xref ref-type="bibr" rid="article-29641.r55">[55]</xref><xref ref-type="bibr" rid="article-29641.r56">[56]</xref> Additionally, intravenous injection of&#x000a0;SP leads to tachypnea in healthy individuals.<xref ref-type="bibr" rid="article-29641.r57">[57]</xref></p>
        <p>
<bold>Gastrointestinal</bold>
</p>
        <p>The gastrointestinal system also contains&#x000a0;SP and NK1 receptors. A well-known function of&#x000a0;SP is its role in the vomiting reflex. In the CNS are areas in the medulla called the area postrema and the nucleus solitarius. These two areas control the vomiting reflex and contain high levels of SP. Emetogenic chemotherapies such as cisplatin and other systemic chemotherapies cause the release of SP, which binds to NK1 receptors triggering emesis. NK1R antagonists, such as aprepitant and its pro-drug fosaprepitant, block&#x000a0;SP from binding to the NK-1 receptor. This blockade prevents the signaling of the vomiting reflex, hopefully lessening the severity of chemotherapy-induced emesis.<xref ref-type="bibr" rid="article-29641.r58">[58]</xref><xref ref-type="bibr" rid="article-29641.r59">[59]</xref></p>
        <p>Additionally, enteric motor neurons of the GI tract release acetylcholine and SP onto smooth muscle, regulating gastric motility; it appears that&#x000a0;SP increases the sensitivity of GI tract smooth muscle to acetylcholine, the major neurotransmitter for GI smooth muscle contractions.<xref ref-type="bibr" rid="article-29641.r60">[60]</xref></p>
        <p>
<bold>Integument</bold>
</p>
        <p>NK1 receptors are found on the surface of mast cells and contribute to the pathogenesis of eczema and psoriasis. Through neurogenic inflammation,&#x000a0;SP is released from the sensory neurons of damaged tissue. SP leads to the production of inflammatory cytokines and the degranulation of mast cells. The release of histamine from granules causes increased capillary permeability and edema. These events lead to the five cardinal signs of inflammation: redness, heat, swelling, pain, and loss of function.<xref ref-type="bibr" rid="article-29641.r61">[61]</xref></p>
      </sec>
      <sec id="article-29641.s7" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Substance P&#x000a0;works through a G protein-coupled receptor, either through the IP3/DAG pathway or the cAMP pathway depending on cell type. In the dorsal horn,&#x000a0;SP assists in transmitting pain signals to the central nervous system. In the gastrointestinal tract,&#x000a0;SP helps potentiate smooth muscle contraction in response to acetylcholine and serotonin from post-synaptic neurons.<xref ref-type="bibr" rid="article-29641.r60">[60]</xref></p>
        <p>In response to skin damage,&#x000a0;SP and CGRP are products released from afferent nerve terminals involved in neurogenic inflammation. After its release,&#x000a0;SP acts on the endothelium indirectly through mast cells by increasing its permeability (through the degranulation of mast cells) and directly upregulating cell adhesion molecules, assisting in cell chemotaxis and diapedesis.<xref ref-type="bibr" rid="article-29641.r49">[49]</xref><xref ref-type="bibr" rid="article-29641.r61">[61]</xref></p>
      </sec>
      <sec id="article-29641.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Substance P has been implicated in the pathogenesis of&#x000a0;several diseases.<xref ref-type="bibr" rid="article-29641.r62">[62]</xref><xref ref-type="bibr" rid="article-29641.r63">[63]</xref><xref ref-type="bibr" rid="article-29641.r64">[64]</xref><xref ref-type="bibr" rid="article-29641.r54">[54]</xref> These include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Emesis</p>
          </list-item>
          <list-item>
            <p>Fibromyalgia</p>
          </list-item>
          <list-item>
            <p>Eczema</p>
          </list-item>
          <list-item>
            <p>Psoriasis</p>
          </list-item>
          <list-item>
            <p>Depression</p>
          </list-item>
          <list-item>
            <p>Anxiety</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
          <list-item>
            <p>Myocardial infarction</p>
          </list-item>
          <list-item>
            <p>Myocardial reperfusion injury</p>
          </list-item>
          <list-item>
            <p>Asthma</p>
          </list-item>
          <list-item>
            <p>Chronic bronchitis</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel diseases</p>
          </list-item>
          <list-item>
            <p>Migraine</p>
          </list-item>
          <list-item>
            <p>Osteoarthritis</p>
          </list-item>
          <list-item>
            <p>Rheumatoid arthritis</p>
          </list-item>
          <list-item>
            <p>Bipolar disorder</p>
          </list-item>
          <list-item>
            <p>Epilepsy</p>
          </list-item>
          <list-item>
            <p>Alzheimer disease</p>
          </list-item>
          <list-item>
            <p>Cardiomyopathies</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29641.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>While novel therapies involving&#x000a0;substance P and NK-1R antagonists are currently undergoing clinical testing, the most significant clinical impact of&#x000a0;SP research is as NK-1 receptor antagonists. NK-1 receptor antagonists were initially tested as antidepressants, but research revealed an antiemetic effect. Aprepitant and its prodrug fosaprepitant are NK-1 receptor antagonists used as antiemetic agents. Aprepitant is available by oral and intravenous (IV) administration, and fosaprepitant are only available intravenously (IV). Both drugs are useful for&#x000a0;preventing nausea and vomiting associated with chemotherapy agents. Netupitant, an NK-1 receptor antagonist only available by oral administration, is also used as an antiemetic agent and is combined with palonosetron.<xref ref-type="bibr" rid="article-29641.r65">[65]</xref></p>
        <p>These drugs are administered prophylactically before chemotherapy treatment to reduce nausea and vomiting. Aprepitant may be used for the treatment of chronic refractory pruritus.<xref ref-type="bibr" rid="article-29641.r66">[66]</xref> Fosaprepitant, a prodrug of aprepitant, is converted by hepatic enzymes in the body into aprepitant, the biologically active molecule.<xref ref-type="bibr" rid="article-29641.r67">[67]</xref><xref ref-type="bibr" rid="article-29641.r68">[68]</xref>&#x000a0;SP/NK1R antagonists are currently being researched as antidepressants, anxiolytics, and anti-inflammatory drugs.<xref ref-type="bibr" rid="article-29641.r69">[69]</xref> These drugs are all moderate inhibitors of the CYP3A4 metabolic pathway, and dose reductions of certain drugs may be needed.</p>
        <p>Capsaicin, a molecule found in chili peppers, has been shown to decrease the amount of SP at the terminal and peripheral nerve endings of afferent nerves. Due to SP's role in pain transmission, capsaicin decreases the awareness of painful stimuli.<xref ref-type="bibr" rid="article-29641.r70">[70]</xref><xref ref-type="bibr" rid="article-29641.r71">[71]</xref><xref ref-type="bibr" rid="article-29641.r72">[72]</xref> Capsaicin interferes with a molecule called nerve growth factor (NGF), which is necessary for the synthesis of SP. Capsaicin cream is used for pain relief, especially in arthritis, post-herpetic neuralgia, shingles, fibromyalgia, and peripheral diabetic neuropathy.<xref ref-type="bibr" rid="article-29641.r73">[73]</xref><xref ref-type="bibr" rid="article-29641.r74">[74]</xref><xref ref-type="bibr" rid="article-29641.r75">[75]</xref></p>
      </sec>
      <sec id="article-29641.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29641&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29641">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29641/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29641">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29641.s11">
        <fig id="article-29641.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Substance P molecular structure Wikipedia Commons titled "Skeletal formula of substance P." Created using ACD/ChemSketch 10.0 and Inkscape. by Author Fvasconcellos 22:22, 13 June 2007 (UTC), who released it on public domain.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1280px-Substance_P.svg" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29641.s12">
        <title>References</title>
        <ref id="article-29641.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinhoff</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>von Mentzer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Geppetti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pothoulakis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bunnett</surname>
                <given-names>NW</given-names>
              </name>
            </person-group>
            <article-title>Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.</article-title>
            <source>Physiol Rev</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>265</fpage>
            <page-range>265-301</page-range>
            <pub-id pub-id-type="pmid">24382888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Connor</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Goode</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bredin</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Shanahan</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The role of substance P in inflammatory disease.</article-title>
            <source>J Cell Physiol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>201</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-80</page-range>
            <pub-id pub-id-type="pmid">15334652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerard</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Garraway</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Shows</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Iijima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Paquet</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Gerard</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones.</article-title>
            <source>Biochemistry</source>
            <year>1991</year>
            <month>Nov</month>
            <day>05</day>
            <volume>30</volume>
            <issue>44</issue>
            <fpage>10640</fpage>
            <page-range>10640-6</page-range>
            <pub-id pub-id-type="pmid">1657150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derocq</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>S&#x000e9;gui</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blazy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Emonds-Alt</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Le Fur</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brelire</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Casellas</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists.</article-title>
            <source>FEBS Lett</source>
            <year>1996</year>
            <month>Dec</month>
            <day>16</day>
            <volume>399</volume>
            <issue>3</issue>
            <fpage>321</fpage>
            <page-range>321-5</page-range>
            <pub-id pub-id-type="pmid">8985172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mistrova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kruzliak</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chottova Dvorakova</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Role of substance P in the cardiovascular system.</article-title>
            <source>Neuropeptides</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>58</volume>
            <fpage>41</fpage>
            <page-range>41-51</page-range>
            <pub-id pub-id-type="pmid">26706184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fiebich</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Schleicher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Butcher</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lieb</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B.</article-title>
            <source>J Immunol</source>
            <year>2000</year>
            <month>Nov</month>
            <day>15</day>
            <volume>165</volume>
            <issue>10</issue>
            <fpage>5606</fpage>
            <page-range>5606-11</page-range>
            <pub-id pub-id-type="pmid">11067916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>WZ</given-names>
              </name>
            </person-group>
            <article-title>Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes.</article-title>
            <source>J Neuroimmunol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>131</volume>
            <issue>1-2</issue>
            <fpage>160</fpage>
            <page-range>160-7</page-range>
            <pub-id pub-id-type="pmid">12458047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koizumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yasui</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fukaya</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ueda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ohkawara</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Substance P induces inositol 1,4,5-trisphosphate and intracellular free calcium increase in cultured normal human epidermal keratinocytes.</article-title>
            <source>Exp Dermatol</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-4</page-range>
            <pub-id pub-id-type="pmid">7520337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koon</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Simeonidis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moyer</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Pothoulakis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation.</article-title>
            <source>J Pharmacol Exp Ther</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>314</volume>
            <issue>3</issue>
            <fpage>1393</fpage>
            <page-range>1393-400</page-range>
            <pub-id pub-id-type="pmid">15917399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lieb</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fiebich</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schulze-Osthoff</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells.</article-title>
            <source>J Immunol</source>
            <year>1997</year>
            <month>Nov</month>
            <day>15</day>
            <volume>159</volume>
            <issue>10</issue>
            <fpage>4952</fpage>
            <page-range>4952-8</page-range>
            <pub-id pub-id-type="pmid">9366421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quinlan</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Bunnett</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Ansel</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Caughman</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Substance P activates coincident NF-AT- and NF-kappa B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization.</article-title>
            <source>J Immunol</source>
            <year>1999</year>
            <month>Nov</month>
            <day>15</day>
            <volume>163</volume>
            <issue>10</issue>
            <fpage>5656</fpage>
            <page-range>5656-65</page-range>
            <pub-id pub-id-type="pmid">10553096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ramnath</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Zhi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tamizhselvi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Substance P enhances NF-kappaB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways.</article-title>
            <source>Am J Physiol Cell Physiol</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>294</volume>
            <issue>6</issue>
            <fpage>C1586</fpage>
            <page-range>C1586-96</page-range>
            <pub-id pub-id-type="pmid">18434625</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McConalogue</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Corvera</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>Gamp</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Grady</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Bunnett</surname>
                <given-names>NW</given-names>
              </name>
            </person-group>
            <article-title>Desensitization of the neurokinin-1 receptor (NK1-R) in neurons: effects of substance P on the distribution of NK1-R, Galphaq/11, G-protein receptor kinase-2/3, and beta-arrestin-1/2.</article-title>
            <source>Mol Biol Cell</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>8</issue>
            <fpage>2305</fpage>
            <page-range>2305-24</page-range>
            <pub-id pub-id-type="pmid">9693383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beinborn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Setiawan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schroeder</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Stoyanoff</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>TGF-beta regulates T-cell neurokinin-1 receptor internalization and function.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2010</year>
            <month>Mar</month>
            <day>02</day>
            <volume>107</volume>
            <issue>9</issue>
            <fpage>4293</fpage>
            <page-range>4293-8</page-range>
            <pub-id pub-id-type="pmid">20160079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinstock</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Substance P and the regulation of inflammation in infections and inflammatory bowel disease.</article-title>
            <source>Acta Physiol (Oxf)</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>213</volume>
            <issue>2</issue>
            <fpage>453</fpage>
            <page-range>453-61</page-range>
            <pub-id pub-id-type="pmid">25424746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinstock</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Metwali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elliott</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Arsenescu</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>IL-18 and IL-12 signal through the NF-kappa B pathway to induce NK-1R expression on T cells.</article-title>
            <source>J Immunol</source>
            <year>2003</year>
            <month>May</month>
            <day>15</day>
            <volume>170</volume>
            <issue>10</issue>
            <fpage>5003</fpage>
            <page-range>5003-7</page-range>
            <pub-id pub-id-type="pmid">12734344</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malcangio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bowery</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Peptide autoreceptors: does an autoreceptor for substance P exist?</article-title>
            <source>Trends Pharmacol Sci</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>10</issue>
            <fpage>405</fpage>
            <page-range>405-7</page-range>
            <pub-id pub-id-type="pmid">10577252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patacchini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maggi</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Holzer</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Tachykinin autoreceptors in the gut.</article-title>
            <source>Trends Pharmacol Sci</source>
            <year>2000</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>166</fpage>
            <pub-id pub-id-type="pmid">10785646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nyberg</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Le Greves</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundqvist</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Terenius</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Characterization of substance P(1-7) and (1-8) generating enzyme in human cerebrospinal fluid.</article-title>
            <source>Biochem Biophys Res Commun</source>
            <year>1984</year>
            <month>Nov</month>
            <day>30</day>
            <volume>125</volume>
            <issue>1</issue>
            <fpage>244</fpage>
            <page-range>244-50</page-range>
            <pub-id pub-id-type="pmid">6210084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skidgel</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Engelbrecht</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Erd&#x000f6;s</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase.</article-title>
            <source>Peptides</source>
            <year>1984</year>
            <season>Jul-Aug</season>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>769</fpage>
            <page-range>769-76</page-range>
            <pub-id pub-id-type="pmid">6208535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suvas</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.</article-title>
            <source>J Immunol</source>
            <year>2017</year>
            <month>Sep</month>
            <day>01</day>
            <volume>199</volume>
            <issue>5</issue>
            <fpage>1543</fpage>
            <page-range>1543-1552</page-range>
            <pub-id pub-id-type="pmid">28827386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Severini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Improta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Falconieri-Erspamer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salvadori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Erspamer</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The tachykinin peptide family.</article-title>
            <source>Pharmacol Rev</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>54</volume>
            <issue>2</issue>
            <fpage>285</fpage>
            <page-range>285-322</page-range>
            <pub-id pub-id-type="pmid">12037144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hirose</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takashima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Inayama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakanishi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor.</article-title>
            <source>Nature</source>
            <year>1983</year>
            <month>Nov</month>
            <day>3-9</day>
            <volume>306</volume>
            <issue>5938</issue>
            <fpage>32</fpage>
            <page-range>32-6</page-range>
            <pub-id pub-id-type="pmid">6195531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carter</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma.</article-title>
            <source>J Neurosci</source>
            <year>1990</year>
            <month>Jul</month>
            <volume>10</volume>
            <issue>7</issue>
            <fpage>2203</fpage>
            <page-range>2203-14</page-range>
            <pub-id pub-id-type="pmid">1695945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pennefather</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Lecci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Candenas</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Patak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pinto</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Maggi</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Tachykinins and tachykinin receptors: a growing family.</article-title>
            <source>Life Sci</source>
            <year>2004</year>
            <month>Feb</month>
            <day>06</day>
            <volume>74</volume>
            <issue>12</issue>
            <fpage>1445</fpage>
            <page-range>1445-63</page-range>
            <pub-id pub-id-type="pmid">14729395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Page</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Hemokinins and endokinins.</article-title>
            <source>Cell Mol Life Sci</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>61</volume>
            <issue>13</issue>
            <fpage>1652</fpage>
            <page-range>1652-63</page-range>
            <pub-id pub-id-type="pmid">15224188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harmar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Keen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Synthesis, and central and peripheral axonal transport of substance P in a dorsal root ganglion-nerve preparation in vitro.</article-title>
            <source>Brain Res</source>
            <year>1982</year>
            <month>Jan</month>
            <day>14</day>
            <volume>231</volume>
            <issue>2</issue>
            <fpage>379</fpage>
            <page-range>379-85</page-range>
            <pub-id pub-id-type="pmid">6173094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGregor</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Radioimmunoassay of substance P and its stability in tissue.</article-title>
            <source>Life Sci</source>
            <year>1983</year>
            <month>Feb</month>
            <day>07</day>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>655</fpage>
            <page-range>655-62</page-range>
            <pub-id pub-id-type="pmid">6188020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christian</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Payan</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Stimulation of transcriptional regulatory activity by substance P.</article-title>
            <source>Neuroimmunomodulation</source>
            <year>1994</year>
            <season>May-Jun</season>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-64</page-range>
            <pub-id pub-id-type="pmid">7489329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Tachykinin receptor types: Classification and membrane signalling mechanisms.</article-title>
            <source>Neurochem Int</source>
            <year>1991</year>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-65</page-range>
            <pub-id pub-id-type="pmid">20504688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantyh</surname>
                <given-names>PW</given-names>
              </name>
            </person-group>
            <article-title>Neurobiology of substance P and the NK1 receptor.</article-title>
            <source>J Clin Psychiatry</source>
            <year>2002</year>
            <volume>63 Suppl 11</volume>
            <fpage>6</fpage>
            <page-range>6-10</page-range>
            <pub-id pub-id-type="pmid">12562137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maggi</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The mammalian tachykinin receptors.</article-title>
            <source>Gen Pharmacol</source>
            <year>1995</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>911</fpage>
            <page-range>911-44</page-range>
            <pub-id pub-id-type="pmid">7557266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Biasi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Giuffrida</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rustioni</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Substance P-containing projections in the dorsal columns of rats and cats.</article-title>
            <source>Neuroscience</source>
            <year>1990</year>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>607</fpage>
            <page-range>607-21</page-range>
            <pub-id pub-id-type="pmid">1693760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kwak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Murayama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kanazawa</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Substance P is a possible neurotransmitter in the rat spinothalamic tract.</article-title>
            <source>Neurosci Res</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>261</fpage>
            <page-range>261-6</page-range>
            <pub-id pub-id-type="pmid">7538653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dum</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Levinthal</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Strick</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>The spinothalamic system targets motor and sensory areas in the cerebral cortex of monkeys.</article-title>
            <source>J Neurosci</source>
            <year>2009</year>
            <month>Nov</month>
            <day>11</day>
            <volume>29</volume>
            <issue>45</issue>
            <fpage>14223</fpage>
            <page-range>14223-35</page-range>
            <pub-id pub-id-type="pmid">19906970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Koninck</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1991</year>
            <month>Dec</month>
            <day>15</day>
            <volume>88</volume>
            <issue>24</issue>
            <fpage>11344</fpage>
            <page-range>11344-8</page-range>
            <pub-id pub-id-type="pmid">1722327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gouin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>L'Herondelle</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lebonvallet</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Le Gall-Ianotto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sakka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Buh&#x000e9;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pl&#x000e9;e-Gautier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Carr&#x000e9;</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lefeuvre</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Misery</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Le Garrec</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization.</article-title>
            <source>Protein Cell</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>9</issue>
            <fpage>644</fpage>
            <page-range>644-661</page-range>
            <pub-id pub-id-type="pmid">28364279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herbert</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Holzer</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Neurogenic inflammation. I. Basic mechanisms, physiology and pharmacology].</article-title>
            <source>Anasthesiol Intensivmed Notfallmed Schmerzther</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>314</fpage>
            <page-range>314-25</page-range>
            <pub-id pub-id-type="pmid">12063584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Di Nardo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Skin neurogenic inflammation.</article-title>
            <source>Semin Immunopathol</source>
            <year>2018</year>
            <month>May</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>249</fpage>
            <page-range>249-259</page-range>
            <pub-id pub-id-type="pmid">29713744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ahluwalia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Felipe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hunt</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Perretti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Impaired IL-1beta-induced neutrophil accumulation in tachykinin NK1 receptor knockout mice.</article-title>
            <source>Br J Pharmacol</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>1013</fpage>
            <page-range>1013-5</page-range>
            <pub-id pub-id-type="pmid">9720767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kuhnt-Moore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Simeonidis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moyer</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Pothoulakis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases.</article-title>
            <source>Biochem J</source>
            <year>2002</year>
            <month>Dec</month>
            <day>01</day>
            <volume>368</volume>
            <issue>Pt 2</issue>
            <fpage>665</fpage>
            <page-range>665-72</page-range>
            <pub-id pub-id-type="pmid">12169092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tran</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Lausch</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Oakes</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Substance P differentially stimulates IL-8 synthesis in human corneal epithelial cells.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>12</issue>
            <fpage>3871</fpage>
            <page-range>3871-7</page-range>
            <pub-id pub-id-type="pmid">11053288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castellani</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Vecchiet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Theoharides</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Caraffa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Antinolfi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tet&#x000e9;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ciampoli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cuccurullo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cerulli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Felaco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boscolo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells.</article-title>
            <source>Transl Res</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>154</volume>
            <issue>1</issue>
            <fpage>27</fpage>
            <page-range>27-33</page-range>
            <pub-id pub-id-type="pmid">19524871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chernova</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tuluc</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Korchak</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Kilpatrick</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).</article-title>
            <source>J Leukoc Biol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>154</fpage>
            <page-range>154-64</page-range>
            <pub-id pub-id-type="pmid">18835883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okayama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakazawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Church</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Human skin mast cells produce TNF-alpha by substance P.</article-title>
            <source>Int Arch Allergy Immunol</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>117 Suppl 1</volume>
            <fpage>48</fpage>
            <page-range>48-51</page-range>
            <pub-id pub-id-type="pmid">9758897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takashima</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Harnessing DCs by substance P.</article-title>
            <source>Blood</source>
            <year>2013</year>
            <month>Apr</month>
            <day>11</day>
            <volume>121</volume>
            <issue>15</issue>
            <fpage>2815</fpage>
            <page-range>2815-6</page-range>
            <pub-id pub-id-type="pmid">23580632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Janelsins</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Sumpter</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Tkacheva</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Rojas-Canales</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Erdos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mathers</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shufesky</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Storkus</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Falo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Morelli</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Larregina</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Neurokinin-1 receptor agonists bias therapeutic dendritic cells to induce type 1 immunity by licensing host dendritic cells to produce IL-12.</article-title>
            <source>Blood</source>
            <year>2013</year>
            <month>Apr</month>
            <day>11</day>
            <volume>121</volume>
            <issue>15</issue>
            <fpage>2923</fpage>
            <page-range>2923-33</page-range>
            <pub-id pub-id-type="pmid">23365459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mathers</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Tckacheva</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Janelsins</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Shufesky</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Morelli</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Larregina</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>In vivo signaling through the neurokinin 1 receptor favors transgene expression by Langerhans cells and promotes the generation of Th1- and Tc1-biased immune responses.</article-title>
            <source>J Immunol</source>
            <year>2007</year>
            <month>Jun</month>
            <day>01</day>
            <volume>178</volume>
            <issue>11</issue>
            <fpage>7006</fpage>
            <page-range>7006-17</page-range>
            <pub-id pub-id-type="pmid">17513750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matis</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Lavker</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>GF</given-names>
              </name>
            </person-group>
            <article-title>Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium.</article-title>
            <source>J Invest Dermatol</source>
            <year>1990</year>
            <month>Apr</month>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>492</fpage>
            <page-range>492-5</page-range>
            <pub-id pub-id-type="pmid">1690249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maxwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Cuss</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Ventilatory effects of substance P, vasoactive intestinal peptide, and nitroprusside in humans.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>1990</year>
            <month>Jan</month>
            <volume>68</volume>
            <issue>1</issue>
            <fpage>295</fpage>
            <page-range>295-301</page-range>
            <pub-id pub-id-type="pmid">1690202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ustinova</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Bergren</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P.</article-title>
            <source>Cardiovasc Res</source>
            <year>1995</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-63</page-range>
            <pub-id pub-id-type="pmid">7553724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Degeneration of capsaicin sensitive sensory nerves enhances myocardial injury in acute myocardial infarction in rats.</article-title>
            <source>Int J Cardiol</source>
            <year>2012</year>
            <month>Sep</month>
            <day>20</day>
            <volume>160</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-7</page-range>
            <pub-id pub-id-type="pmid">21470700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dehlin</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Levick</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Substance P in heart failure: the good and the bad.</article-title>
            <source>Int J Cardiol</source>
            <year>2014</year>
            <month>Jan</month>
            <day>01</day>
            <volume>170</volume>
            <issue>3</issue>
            <fpage>270</fpage>
            <page-range>270-7</page-range>
            <pub-id pub-id-type="pmid">24286592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feickert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burckhardt</surname>
                <given-names>BB</given-names>
              </name>
            </person-group>
            <article-title>Substance P in cardiovascular diseases - A bioanalytical review.</article-title>
            <source>Clin Chim Acta</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>495</volume>
            <fpage>501</fpage>
            <page-range>501-506</page-range>
            <pub-id pub-id-type="pmid">31103623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heaney</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Stanford</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Ennis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Substance P induces histamine release from human pulmonary mast cells.</article-title>
            <source>Clin Exp Allergy</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-86</page-range>
            <pub-id pub-id-type="pmid">7538443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harrison</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Geppetti</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Substance p.</article-title>
            <source>Int J Biochem Cell Biol</source>
            <year>2001</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>6</issue>
            <fpage>555</fpage>
            <page-range>555-76</page-range>
            <pub-id pub-id-type="pmid">11378438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuller</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Maxwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>McGregor</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Bloom</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Effect of substance P on cardiovascular and respiratory function in subjects.</article-title>
            <source>J Appl Physiol (1985)</source>
            <year>1987</year>
            <month>Apr</month>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>1473</fpage>
            <page-range>1473-9</page-range>
            <pub-id pub-id-type="pmid">2439484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darmani</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abad</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ray</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Thrush</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists.</article-title>
            <source>Brain Res</source>
            <year>2008</year>
            <month>Jun</month>
            <day>12</day>
            <volume>1214</volume>
            <fpage>58</fpage>
            <page-range>58-72</page-range>
            <pub-id pub-id-type="pmid">18471804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ray</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Chebolu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Darmani</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Ablation of least shrew central neurokinin NK1 receptors reduces GR73632-induced vomiting.</article-title>
            <source>Behav Neurosci</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>123</volume>
            <issue>3</issue>
            <fpage>701</fpage>
            <page-range>701-6</page-range>
            <pub-id pub-id-type="pmid">19485577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Micci</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Pasricha</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Substance P is essential for maintaining gut muscle contractility: a novel role for coneurotransmission revealed by botulinum toxin.</article-title>
            <source>Am J Physiol Gastrointest Liver Physiol</source>
            <year>2014</year>
            <month>May</month>
            <day>15</day>
            <volume>306</volume>
            <issue>10</issue>
            <fpage>G839</fpage>
            <page-range>G839-48</page-range>
            <pub-id pub-id-type="pmid">24699329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foreman</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin.</article-title>
            <source>Int Arch Allergy Appl Immunol</source>
            <year>1987</year>
            <volume>82</volume>
            <issue>3-4</issue>
            <fpage>366</fpage>
            <page-range>366-71</page-range>
            <pub-id pub-id-type="pmid">2437050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perlis</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Purcell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fagerness</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petryshen</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sklar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Family-based association study of lithium-related and other candidate genes in bipolar disorder.</article-title>
            <source>Arch Gen Psychiatry</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>65</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-61</page-range>
            <pub-id pub-id-type="pmid">18180429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Substance P Regulation in Epilepsy.</article-title>
            <source>Curr Neuropharmacol</source>
            <year>2018</year>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-50</page-range>
            <pub-id pub-id-type="pmid">28474564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Severini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Petrella</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Calissano</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Substance P and Alzheimer's Disease: Emerging Novel Roles.</article-title>
            <source>Curr Alzheimer Res</source>
            <year>2016</year>
            <volume>13</volume>
            <issue>9</issue>
            <fpage>964</fpage>
            <page-range>964-72</page-range>
            <pub-id pub-id-type="pmid">27033058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keating</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Netupitant/Palonosetron: A Review in the Prevention of Chemotherapy-Induced Nausea and Vomiting.</article-title>
            <source>Drugs</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>75</volume>
            <issue>18</issue>
            <fpage>2131</fpage>
            <page-range>2131-41</page-range>
            <pub-id pub-id-type="pmid">26613606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alhariri</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sweren</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kwatra</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Kwatra</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Aprepitant for the Treatment of Chronic Refractory Pruritus.</article-title>
            <source>Biomed Res Int</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>4790810</fpage>
            <pub-id pub-id-type="pmid">29057261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Candelario</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives.</article-title>
            <source>Cancer Manag Res</source>
            <year>2016</year>
            <volume>8</volume>
            <fpage>77</fpage>
            <page-range>77-82</page-range>
            <pub-id pub-id-type="pmid">27382332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jordan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Neurokinin-1-receptor antagonists: a new approach in antiemetic therapy.</article-title>
            <source>Onkologie</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>1-2</issue>
            <fpage>39</fpage>
            <page-range>39-43</page-range>
            <pub-id pub-id-type="pmid">16514255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Aprepitant in the prevention of vomiting induced by moderately and highly emetogenic chemotherapy.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2014</year>
            <volume>15</volume>
            <issue>23</issue>
            <fpage>10045</fpage>
            <page-range>10045-51</page-range>
            <pub-id pub-id-type="pmid">25556423</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anand</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bley</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch.</article-title>
            <source>Br J Anaesth</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>107</volume>
            <issue>4</issue>
            <fpage>490</fpage>
            <page-range>490-502</page-range>
            <pub-id pub-id-type="pmid">21852280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Vij</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms and clinical uses of capsaicin.</article-title>
            <source>Eur J Pharmacol</source>
            <year>2013</year>
            <month>Nov</month>
            <day>15</day>
            <volume>720</volume>
            <issue>1-3</issue>
            <fpage>55</fpage>
            <page-range>55-62</page-range>
            <pub-id pub-id-type="pmid">24211679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roosterman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Goerge</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Bunnett</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Steinhoff</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.</article-title>
            <source>Physiol Rev</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>86</volume>
            <issue>4</issue>
            <fpage>1309</fpage>
            <page-range>1309-79</page-range>
            <pub-id pub-id-type="pmid">17015491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burks</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Buck</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of depletion of substance P by capsaicin.</article-title>
            <source>Fed Proc</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>9</issue>
            <fpage>2531</fpage>
            <page-range>2531-4</page-range>
            <pub-id pub-id-type="pmid">2581820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernandes</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Cerqueira</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Capsaicin and Its Role in Chronic Diseases.</article-title>
            <source>Adv Exp Med Biol</source>
            <year>2016</year>
            <volume>929</volume>
            <fpage>91</fpage>
            <page-range>91-125</page-range>
            <pub-id pub-id-type="pmid">27771922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29641.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Cole</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Topical capsaicin (high concentration) for chronic neuropathic pain in adults.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <day>13</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD007393</fpage>
            <pub-id pub-id-type="pmid">28085183</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
